Table 2.
Percentage (standard deviation in brackets) of specified T cells expressing markers of differentiation/homing
| CD62L | CCR7 | CD28 | CD27 | |
|---|---|---|---|---|
| EBV-specific CD8+ | 7·6% (1·8) | 15·8% (2·8) | 67·4% (19·9) | 93·0% (5·4) |
| CLA+ CD8+ | 65·0% (7·6)12 | 72·8% (8·7)12 | 80·0% (5·4) | 82·6% (6·2) |
| CLA− CD8+ | 25·0% (6·2) | 35·0% (4·2) | 83·0% (5·0) | 90·8% (4·1) |
1
Significant (P < 0·01) difference in expression of marker between CLA+ CD8+ T cells and CLA−CD8+ T cells.
2
Significant (P < 0·01) difference in expression of marker between CLA+ CD8+ T and Epstein Barr virus (EBV)-specific CD8+ T cells.